Compare YELP & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YELP | HROW |
|---|---|---|
| Founded | 2004 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 2012 | N/A |
| Metric | YELP | HROW |
|---|---|---|
| Price | $27.31 | $40.64 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | $31.60 | ★ $68.86 |
| AVG Volume (30 Days) | ★ 965.9K | 579.2K |
| Earning Date | 02-12-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.30 | N/A |
| EPS | ★ 2.25 | N/A |
| Revenue | ★ $1,466,918,000.00 | $250,042,000.00 |
| Revenue This Year | $5.73 | $38.57 |
| Revenue Next Year | $2.81 | $42.17 |
| P/E Ratio | $12.19 | ★ N/A |
| Revenue Growth | 5.34 | ★ 47.83 |
| 52 Week Low | $26.96 | $20.85 |
| 52 Week High | $41.72 | $54.85 |
| Indicator | YELP | HROW |
|---|---|---|
| Relative Strength Index (RSI) | 32.85 | 31.23 |
| Support Level | $26.96 | $44.55 |
| Resistance Level | $29.58 | $44.05 |
| Average True Range (ATR) | 0.86 | 2.08 |
| MACD | -0.19 | -0.96 |
| Stochastic Oscillator | 9.22 | 1.26 |
Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making better buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.